Position in SCLX
as of Jun 30, 2026
· filed Sep 2, 2026
Position Value
$214,475
+$139,921 QoQ
Shares Held
27,497
+35.3% QoQ
Ownership
0.324%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 72 holders
Holding Since
Mar 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Derivatives in SCLX
reported options exposure · as of Mar 31, 2025CallValue
$3,236
CallShares
597
PutValue
$2,838
PutShares
523
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $3,979,998,649 across 21 Drug Manufacturers - General names. SCLX ranks #18 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
945,456 | $1,134,008,383 | |
| 2 | ABBV |
AbbVie Inc.
|
3,169,783 | $797,644,194 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
3,480,444 | $439,719,294 | |
| 4 | JNJ |
Johnson & Johnson
|
1,500,832 | $381,166,302 | |
| 5 | AMGN |
Amgen Inc
|
703,984 | $254,926,685 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,933,667 | $248,476,209 | |
| 7 | AZN |
Astrazeneca PLC
|
970,043 | $183,939,553 | |
| 8 | PFE |
Pfizer Inc
|
6,191,186 | $149,083,758 |
All Filings in SCLX
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $214,475 | 27,497 | Shares | Defined | 2026-09-02 | |
| 2025-06-30 | $74,554 | 12,658 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,236 | 13,000 | Call | Defined | 2025-05-15 | |
| 2025-03-31 | $37,258 | 149,635 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $2,838 | 11,400 | Put | Defined | 2025-05-15 | |
| 2024-12-31 | $5,154 | 12,100 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $7,795 | 18,300 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $63,678 | 149,481 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $52,355 | 56,600 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $551,440 | 596,152 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $54,020 | 58,400 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $18,527 | 9,600 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $306,085 | 158,594 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $37,248 | 19,300 | Call | Defined | 2024-08-14 | |
| 2024-03-31 | $258,153 | 162,361 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $7,949 | 5,000 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $3,338 | 2,100 | Put | Defined | 2024-05-15 | |
| 2023-12-31 | $13,668 | 6,700 | Put | Defined | 2024-02-14 | |
| 2023-12-31 | $204 | 100 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $305,559 | 149,784 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $8,820 | 6,300 | Put | Defined | 2023-11-14 | |
| 2023-09-30 | $174,617 | 124,727 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $6,300 | 4,500 | Call | Defined | 2023-11-14 | |
| 2023-06-30 | $233,382 | 41,900 | Put | Defined | 2023-08-14 | |
| 2023-06-30 | $694,729 | 124,727 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $32,305 | 5,800 | Call | Defined | 2023-08-14 | |
| 2023-03-31 | $359,299 | 43,817 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $64,717 | 16,220 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||